Who is sponsoring NCT00004234?

NCT00004234 is sponsored by NCIC Clinical Trials Group.

What condition does NCT00004234 study?

NCT00004234 studies Head and Neck Cancer, Oral Complications.

What drugs are being tested in NCT00004234?

Interventions: management of therapy complications, radiation therapy.

What is the status of NCT00004234?

NCT00004234 is currently COMPLETED.

Last reviewed 2020-04-06 · How we verify

Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx

NCT00004234 PHASE3 COMPLETED

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation therapy at different times of the day may affect the chance of developing side effects such as mucositis. PURPOSE: Randomized phase III trial to compare the incidence of mucositis in patients who have cancer of the mouth, pharynx, or larynx, who are receiving radiation therapy in either the morning or afternoon.

Details

Lead sponsor	NCIC Clinical Trials Group
Phase	PHASE3
Status	COMPLETED
Start date	Mon Aug 02 1999 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Feb 10 2009 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Head and Neck Cancer
Oral Complications

Interventions

management of therapy complications
radiation therapy

Countries

Canada